Reported Standalone quarterly numbers for Ajooni Biotech Ltd. are:Net Sales at Rs 15.85 crore in June 2021 up 61.18% from Rs. 9.83 crore in June 2020.
Quarterly Net Profit at Rs. 0.31 crore in June 2021 up 3.88% from Rs. 0.30 crore in June 2020.
EBITDA stands at Rs. 0.73 crore in June 2021 up 4.29% from Rs. 0.70 crore in June 2020.
Ajooni Biotech EPS has decreased to Rs. 0.31 in June 2021 from Rs. 0.36 in June 2020.
Ajooni Biotech shares closed at 51.35 on August 25, 2021 (NSE) and has given 83.46% returns over the last 6 months and 64.16% over the last 12 months.
| Ajooni Biotech Ltd. | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'21 | Mar'21 | Jun'20 | | Net Sales/Income from operations | 15.85 | 16.19 | 9.83 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 15.85 | 16.19 | 9.83 | | EXPENDITURE | | Consumption of Raw Materials | 13.43 | 13.95 | 8.15 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.01 | -0.23 | -0.04 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.38 | 0.30 | 0.32 | | Depreciation | 0.19 | 0.14 | 0.16 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.33 | 1.83 | 0.71 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.53 | 0.20 | 0.54 | | Other Income | 0.01 | 0.01 | 0.01 | | P/L Before Int., Excpt. Items & Tax | 0.54 | 0.20 | 0.54 | | Interest | 0.13 | 0.15 | 0.10 | | P/L Before Exceptional Items & Tax | 0.41 | 0.05 | 0.44 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.41 | 0.05 | 0.44 | | Tax | 0.09 | 0.00 | 0.14 | | P/L After Tax from Ordinary Activities | 0.31 | 0.04 | 0.30 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 0.31 | 0.04 | 0.30 | | Equity Share Capital | 10.01 | 10.01 | 8.41 | | Reserves Excluding Revaluation Reserves | 5.97 | 5.47 | 7.49 | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.31 | 0.04 | 0.36 | | Diluted EPS | 0.31 | 0.04 | 0.36 | | EPS After Extra Ordinary | | Basic EPS | 0.31 | 0.04 | 0.36 | | Diluted EPS | 0.31 | 0.04 | 0.36 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
